Wenqi X. Li

Tianjin Key Laboratory Of Molecular Drug Research
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Correction: Li et al. Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation. Molecules 2023, 28, 6035.

Correction: Li et al. Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation. Molecules 2023, 28, 6035.

Journal: Molecules (Basel, Switzerland)

Published: April 17, 2026

Correction: Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.

Correction: Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.

Journal: Molecular medicine (Cambridge, Mass.)

Published: September 23, 2025

Genetically regulated omics integration improves genomic prediction of complex traits in pigs.

Genetically regulated omics integration improves genomic prediction of complex traits in pigs.

Journal: Animal : an international journal of animal bioscience

Published: September 09, 2025

Symptom network analysis of fear of recurrence and burden in postoperative lung cancer: A simulation-based intervention study.

Symptom network analysis of fear of recurrence and burden in postoperative lung cancer: A simulation-based intervention study.

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society

Published: September 08, 2025

Author Correction: Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2.

Author Correction: Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2.

Journal: Scientific reports

Published: July 28, 2025

Clinical characteristics and treatment challenges of esophageal sarcomatoid carcinoma: a single-center retrospective cohort study.

Clinical characteristics and treatment challenges of esophageal sarcomatoid carcinoma: a single-center retrospective cohort study.

Journal: Journal of thoracic disease

Published: June 07, 2025

Corrigendum to "Baricitinib alleviates cardiac fibrosis and inflammation induced by chronic sympathetic activation" [Int. Immunopharmacol. 140 (2024) 112894].

Corrigendum to "Baricitinib alleviates cardiac fibrosis and inflammation induced by chronic sympathetic activation" [Int. Immunopharmacol. 140 (2024) 112894].

Journal: International immunopharmacology

Published: June 03, 2025

Lenalidomide attenuates cardiac fibrosis and inflammation induced by β-adrenergic receptor activation.

Lenalidomide attenuates cardiac fibrosis and inflammation induced by β-adrenergic receptor activation.

Journal: International immunopharmacology

Published: January 23, 2025

Ruxolitinib attenuates bleomycin-induced pulmonary fibrosis in mice by modulating macrophage polarization through the JAK/STAT signaling pathway.

Ruxolitinib attenuates bleomycin-induced pulmonary fibrosis in mice by modulating macrophage polarization through the JAK/STAT signaling pathway.

Journal: International immunopharmacology

Published: October 20, 2024

Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2.

Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2.

Journal: Scientific reports

Published: September 29, 2024

Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.

Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.

Journal: Molecular medicine (Cambridge, Mass.)

Published: September 12, 2024

Nerandomilast Improves Bleomycin-Induced Systemic Sclerosis-Associated Interstitial Lung Disease in Mice by Regulating the TGF-β1 Pathway.

Nerandomilast Improves Bleomycin-Induced Systemic Sclerosis-Associated Interstitial Lung Disease in Mice by Regulating the TGF-β1 Pathway.

Journal: Inflammation

Published: August 15, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026